Nettet23. des. 2024 · See the Company's Report on Voting Results filed under the Company's profile on SEDAR at www.sedar.com for additional details. About Intellipharmaceutics Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and … Nettet21. jul. 2024 · Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs.

Intellipharmaceutics Announces First Quarter 2024 Results

Nettet14. okt. 2024 · The condensed unaudited interim consolidated financial statements, accompanying notes to the condensed unaudited interim consolidated financial statements, and Management Discussion and Analysis for the three and nine months ended August 31, 2024 will be accessible on Intellipharmaceutics' website at … Nettet30. nov. 2024 · Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of development. The Company has ANDA and NDA 505 (b) (2) drug product candidates in its development pipeline. bob sucker

Intellipharmaceutics Announces Cease Trade Order Placera

Nettet15. jul. 2024 · Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic … Nettet18. nov. 2024 · Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic … Nettet15. jul. 2024 · Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. clipsal neo switches